PortfoliosLab logoPortfoliosLab logo
BLFS vs. AVGO
Performance
Return for Risk
Drawdowns
Volatility
Dividends
Financials

Performance

BLFS vs. AVGO - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in BioLife Solutions, Inc. (BLFS) and Broadcom Inc. (AVGO). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, BLFS achieves a 16.21% return, which is significantly higher than AVGO's 11.37% return. Over the past 10 years, BLFS has underperformed AVGO with an annualized return of 30.38%, while AVGO has yielded a comparatively higher 40.82% annualized return.


BLFS

1D
-0.28%
1M
7.66%
6M
16.89%
YTD
16.21%
1Y
28.02%
3Y*
12.72%
5Y*
-8.87%
10Y*
30.38%

AVGO

1D
-3.98%
1M
0.68%
6M
9.44%
YTD
11.37%
1Y
41.00%
3Y*
64.86%
5Y*
54.35%
10Y*
40.82%
*Multi-year figures are annualized to reflect compound growth (CAGR)

BLFS vs. AVGO - Yearly Performance Comparison


2026 (YTD)202520242023202220212020201920182017
BLFS
BioLife Solutions, Inc.
16.21%-6.86%59.75%-10.71%-51.17%-6.57%146.54%34.50%100.50%272.60%
AVGO
Broadcom Inc.
11.37%50.63%110.49%104.18%-13.27%56.48%44.88%29.05%2.18%48.19%

Correlation

The correlation between BLFS and AVGO is 0.14, which is low. Their price movements are largely independent, making them effective diversification partners.


Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

0.14

Correlation (3Y)
Calculated over the trailing 3-year period

0.25

Correlation (5Y)
Calculated over the trailing 5-year period

0.32

Correlation (10Y)
Calculated over the trailing 10-year period

0.27

Correlation (All Time)
Calculated using the full available price history since Aug 6, 2009

0.16

The correlation between BLFS and AVGO shifts across timeframes, from 0.14 (1 year) to 0.32 (5 years), reflecting how their relationship changes across market environments.

Fundamentals

Market Cap

BLFS:

$1.37B

AVGO:

$1.83T

EPS

BLFS:

-$0.21

AVGO:

$6.01

PS Ratio

BLFS:

13.76

AVGO:

24.83

PB Ratio

BLFS:

3.72

AVGO:

21.35

Total Revenue (TTM)

BLFS:

$99.77M

AVGO:

$75.47B

Gross Profit (TTM)

BLFS:

$63.83M

AVGO:

$50.53B

EBITDA (TTM)

BLFS:

-$8.16M

AVGO:

$42.03B

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


BioLife Solutions, Inc.

Broadcom Inc.

Return for Risk

BLFS vs. AVGO — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

BLFS
BLFS Risk / Return Rank: 6363
Overall Rank
BLFS Sharpe Ratio Rank: 6767
Sharpe Ratio Rank
BLFS Sortino Ratio Rank: 6464
Sortino Ratio Rank
BLFS Omega Ratio Rank: 6161
Omega Ratio Rank
BLFS Calmar Ratio Rank: 6363
Calmar Ratio Rank
BLFS Martin Ratio Rank: 6363
Martin Ratio Rank

AVGO
AVGO Risk / Return Rank: 7171
Overall Rank
AVGO Sharpe Ratio Rank: 7373
Sharpe Ratio Rank
AVGO Sortino Ratio Rank: 6969
Sortino Ratio Rank
AVGO Omega Ratio Rank: 6969
Omega Ratio Rank
AVGO Calmar Ratio Rank: 7373
Calmar Ratio Rank
AVGO Martin Ratio Rank: 7171
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

BLFS vs. AVGO - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for BioLife Solutions, Inc. (BLFS) and Broadcom Inc. (AVGO). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.


BLFSAVGODifference
Sharpe ratioReturn per unit of total volatility

-0.25

Sortino ratioReturn per unit of downside risk

-0.26

Omega ratioGain probability vs. loss probability

1.14

1.18

-0.04

Calmar ratioReturn relative to maximum drawdown

0.76

1.44

-0.68

Martin ratioReturn relative to average drawdown

1.66

3.04

-1.37

BLFS vs. AVGO - Sharpe Ratio Comparison

The current BLFS Sharpe Ratio is 0.62, which is comparable to the AVGO Sharpe Ratio of 0.88. The chart below compares the historical Sharpe Ratios of BLFS and AVGO, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Drawdowns

BLFS vs. AVGO - Drawdown Comparison

The maximum BLFS drawdown since its inception was -99.80%, which is greater than AVGO's maximum drawdown of -48.30%. Use the drawdown chart below to compare losses from any high point for BLFS and AVGO.


Loading charts...

Drawdown Indicators


BLFSAVGODifference

Max Drawdown

Largest peak-to-trough decline

-99.80%

-48.30%

-51.50%

Max Drawdown (1Y)

Largest decline over 1 year

-36.96%

-28.67%

-8.29%

Max Drawdown (3Y)

Largest decline over 3 years

-55.82%

-41.15%

-14.67%

Max Drawdown (5Y)

Largest decline over 5 years

-85.14%

-41.15%

-43.99%

Max Drawdown (10Y)

Largest decline over 10 years

-85.14%

-48.30%

-36.84%

Current Drawdown

Current decline from peak

-79.93%

-20.12%

-59.81%

Average Drawdown

Average peak-to-trough decline

-89.22%

-8.04%

-81.18%

Ulcer Index

Depth and duration of drawdowns from previous peaks

16.89%

13.53%

+3.36%

Volatility

BLFS vs. AVGO - Volatility Comparison

The current volatility for BioLife Solutions, Inc. (BLFS) is 12.49%, while Broadcom Inc. (AVGO) has a volatility of 14.74%. This indicates that BLFS experiences smaller price fluctuations and is considered to be less risky than AVGO based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


BLFSAVGODifference

Volatility (1M)

Calculated over the trailing 1-month period

12.49%

14.74%

-2.25%

Volatility (6M)

Calculated over the trailing 6-month period

34.73%

34.43%

+0.30%

Volatility (1Y)

Calculated over the trailing 1-year period

45.24%

47.03%

-1.79%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

66.30%

43.81%

+22.49%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

66.04%

39.64%

+26.40%

Dividends

BLFS vs. AVGO - Dividend Comparison

BLFS has not paid dividends to shareholders, while AVGO's dividend yield for the trailing twelve months is around 0.66%.


PositionTTM20252024202320222021202020192018201720162015
AVGO
Broadcom Inc.
0.66%0.70%0.94%1.71%3.02%2.24%3.05%3.54%3.11%1.87%1.43%1.13%
BLFS
BioLife Solutions, Inc.
0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%

Financials

BLFS vs. AVGO - Financials Comparison

This section allows you to compare key financial metrics between BioLife Solutions, Inc. and Broadcom Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


0.005.00B10.00B15.00B20.00BJulyOctober2022AprilJulyOctober2023AprilJulyOctober2024AprilJulyOctober2025AprilJulyOctober2026April
27.50M
22.19B
(BLFS) Total Revenue
(AVGO) Total Revenue
Values in USD except per share items

BLFS vs. AVGO - Profitability Comparison

The chart below illustrates the profitability comparison between BioLife Solutions, Inc. and Broadcom Inc. over time, highlighting three key metrics: Gross Profit Margin, Operating Margin, and Net Profit Margin.

Gross Margin
Operating Margin
Net Margin
Quarterly
Annual

20.0%30.0%40.0%50.0%60.0%70.0%JulyOctober2022AprilJulyOctober2023AprilJulyOctober2024AprilJulyOctober2025AprilJulyOctober2026April
63.6%
67.2%
Portfolio components
BLFS - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jul 2026, BioLife Solutions, Inc. reported a gross profit of 17.50M and revenue of 27.50M. Therefore, the gross margin over that period was 63.6%.

AVGO - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jul 2026, Broadcom Inc. reported a gross profit of 14.92B and revenue of 22.19B. Therefore, the gross margin over that period was 67.2%.

BLFS - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jul 2026, BioLife Solutions, Inc. reported an operating income of 27.00K and revenue of 27.50M, resulting in an operating margin of 0.1%.

AVGO - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jul 2026, Broadcom Inc. reported an operating income of 10.87B and revenue of 22.19B, resulting in an operating margin of 49.0%.

BLFS - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jul 2026, BioLife Solutions, Inc. reported a net income of 1.19M and revenue of 27.50M, resulting in a net margin of 4.3%.

AVGO - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jul 2026, Broadcom Inc. reported a net income of 9.31B and revenue of 22.19B, resulting in a net margin of 42.0%.


Frequently Asked Questions


BLFS and AVGO have a correlation of 0.14, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

AVGO has higher volatility (14.74%) compared to BLFS (12.49%). In terms of maximum drawdown, BLFS dropped -99.80% vs AVGO's -48.30%.

AVGO currently has the higher Sharpe Ratio (0.88 vs 0.62), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for BLFS and AVGO

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer